AG
Algert Global Portfolio holdings
AUM
$4.77B
1-Year Return
26.99%
This Quarter Return
-4.72%
1 Year Return
+26.99%
3 Year Return
+120.65%
5 Year Return
+271.18%
10 Year Return
+1,083.42%
AUM
$4.04B
AUM Growth
-$207M
(-4.9%)
Cap. Flow
+$96.8M
Cap. Flow
% of AUM
2.39%
Top 10 Holdings %
Top 10 Hldgs %
5.72%
Holding
1,371
New
218
Increased
467
Reduced
361
Closed
211
Top Buys
| 1 |
Ralph Lauren
RL
|
+$11.9M |
| 2 |
Valley National Bancorp
VLY
|
+$11.5M |
| 3 |
Tyson Foods
TSN
|
+$10.5M |
| 4 |
Huron Consulting
HURN
|
+$10.1M |
| 5 |
Manhattan Associates
MANH
|
+$8.93M |
Top Sells
| 1 |
Natera
NTRA
|
+$16.1M |
| 2 |
Unum
UNM
|
+$14.6M |
| 3 |
DoubleVerify
DV
|
+$12.9M |
| 4 |
Veracyte
VCYT
|
+$10.4M |
| 5 |
Donaldson
DCI
|
+$9.97M |
Sector Composition
| 1 | Financials | 15.76% |
| 2 | Technology | 15.53% |
| 3 | Industrials | 14.89% |
| 4 | Healthcare | 12.95% |
| 5 | Consumer Discretionary | 11.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DHC
776
Diversified Healthcare Trust
DHC
$1.05B
| $938K | 0.02% |
390,767
+39,670
| +11% | +$95.2K |
|
777
ESCO Technologies
ESE
$5.3B
| $936K | 0.02% |
+5,881
| New | +$936K |
|
778
Evolus
EOLS
$475M
| $935K | 0.02% |
77,757
+53,370
| +219% | +$642K |
|
779
Iovance Biotherapeutics
IOVA
$861M
| $935K | 0.02% |
280,882
+224,482
| +398% | +$747K |
|
780
Open Lending Corp
LPRO
$253M
| $930K | 0.02% |
336,925
-27,794
| -8% | -$76.7K |
|
781
DXP Enterprises
DXPE
$1.79B
| $926K | 0.02% |
11,255
+280
| +3% | +$23K |
|
782
Hasbro
HAS
$10.9B
| $922K | 0.02% |
+14,990
| New | +$922K |
|
783
John B. Sanfilippo & Son
JBSS
$724M
| $922K | 0.02% |
13,016
+1,030
| +9% | +$73K |
|
784
Procter & Gamble
PG
$368B
| $922K | 0.02% |
5,410
+400
| +8% | +$68.2K |
|
785
Transmedics
TMDX
$3.67B
| $920K | 0.02% |
13,674
+1,120
| +9% | +$75.4K |
|
786
Clover Health Investments
CLOV
$1.55B
| $917K | 0.02% |
255,423
-173,358
| -40% | -$622K |
|
787
Alaska Air
ALK
$7.22B
| $903K | 0.02% |
18,341
-10,410
| -36% | -$513K |
|
788
Protagonist Therapeutics
PTGX
$3.59B
| $903K | 0.02% |
18,665
+945
| +5% | +$45.7K |
|
789
Electronic Arts
EA
$42.6B
| $890K | 0.02% |
+6,160
| New | +$890K |
|
790
Manulife Financial
MFC
$52.4B
| $890K | 0.02% |
+28,525
| New | +$890K |
|
791
NOV
NOV
$4.85B
| $890K | 0.02% |
58,470
-263,340
| -82% | -$4.01M |
|
792
Okta
OKTA
$15.9B
| $890K | 0.02% |
8,459
-10,811
| -56% | -$1.14M |
|
793
Arcosa
ACA
$4.72B
| $886K | 0.02% |
11,489
-48,250
| -81% | -$3.72M |
|
794
ICU Medical
ICUI
$3.3B
| $885K | 0.02% |
6,370
| – | – |
|
795
Novanta
NOVT
$4.14B
| $884K | 0.02% |
+6,910
| New | +$884K |
|
796
Crinetics Pharmaceuticals
CRNX
$3.3B
| $882K | 0.02% |
26,287
-2,490
| -9% | -$83.5K |
|
|
UHT
797
Universal Health Realty Income Trust
UHT
$569M
| $882K | 0.02% |
21,542
| – | – |
|
798
TripAdvisor
TRIP
$2.06B
| $869K | 0.02% |
+61,340
| New | +$869K |
|
799
Wayfair
W
$11.3B
| $869K | 0.02% |
+27,130
| New | +$869K |
|
|
TWO
800
Two Harbors Investment
TWO
$1.06B
| $868K | 0.02% |
64,963
| – | – |
|